Pre-requisites: Basic level biology and biochemistry
Total number of classes: 45
COURSE OBJECTIVES
- Be able to articulate the drug-intrinsic and extrinsic factors that determine drug molecule movement across biological membranes
- To demonstrate understanding in concepts that determine dosage, absorption, distribution, and excretions of drugs, along with model systems connected with these concepts and apply pharmacokinetic principles to explain variation in drug disposition
- To understand the basic concepts of drug delivery and physiochemical properties of the drug
- To demonstrate understanding of different routes of drug administration and different drug delivery systems.
- To understand basics of pharmacodynamics.
Course Outcome
CO1: Explain how physicochemical properties of drugs and nanocarriers influence biopharmaceutical behavior, controlled release, and pharmacokinetic profiles.
CO2: Compare and evaluate various routes of drug delivery-including nano-enabled systems-highlighting the principles of active and passive targeting and the advantages of nanotechnology in overcoming biological barriers.
CO3: Analyze pharmacokinetic parameters (bioavailability, half-life, volume of distribution, clearance) in the context of both conventional and nanotechnology-based drug delivery, and apply kinetic models to predict drug/nanocarrier disposition.
CO4: Describe the mechanisms of drug and nanocarrier absorption, distribution, metabolism, and excretion, emphasizing the role of nano-bio interactions and factors affecting these processes.
CO5: Interpret drug-receptor and nanoparticle-cell interactions, dose-response relationships, and structure-activity relationships, including the therapeutic and adverse effects unique to nanomedicine.
CO6: Critically assess the design and performance of controlled and targeted drug delivery systems, integrating nanoscience principles for improved therapeutic outcomes.
Programme Outcomes (PO) (As given by NBA and ABET)
PO1: Bioscience Knowledge
PO2: Problem Analysis
PO3: Design/Development of Solutions
PO4: Conduct Investigations of complex problems
PO5: Modern tools usage
PO6: Bioscientist and Society
PO7: Environment and Sustainability
PO8: Ethics
PO9: Individual & Team work
PO10: Communication
PO11: Project management & Finance
PO12: Lifelong learning
CO-PO MAPPING:
|
|
PO1
|
PO2
|
PO3
|
PO4
|
PO5
|
PO6
|
PO7
|
PO8
|
PO9
|
PO10
|
PO11
|
PO12
|
CO1
|
|
3
|
1
|
–
|
–
|
–
|
–
|
–
|
–
|
3
|
–
|
–
|
–
|
CO2
|
|
3
|
3
|
2
|
3
|
–
|
–
|
2
|
–
|
3
|
–
|
–
|
–
|
CO3
|
|
3
|
3
|
2
|
–
|
–
|
–
|
–
|
–
|
3
|
–
|
–
|
–
|
CO4
|
|
3
|
2
|
–
|
–
|
–
|
–
|
–
|
–
|
3
|
–
|
–
|
–
|
CO5
|
|
2
|
1
|
–
|
–
|
3
|
2
|
–
|
3
|
3
|
2
|
–
|
–
|
PROGRAM SPECIFIC OUTCOMES (PSO):
PSO1: Mastery of Nanomaterial Science and Characterization
PSO2: Understanding of Cellular and Molecular Systems
PSO3: Application of Nanobiotech in Diagnostics and Therapy
PSO4: Experimental Design and Data Analysis
PSO5: Research Competency and Methodological Rigor
PSO6: Industry and Career Readiness
CO-PSO MAPPING:
|
PSO1
|
PSO2
|
PSO3
|
PSO4
|
PSO5
|
PSO6
|
CO1
|
3
|
–
|
–
|
–
|
2
|
–
|
CO2
|
3
|
–
|
–
|
–
|
–
|
–
|
CO3
|
3
|
1
|
1
|
–
|
2
|
–
|
CO4
|
3
|
1
|
1
|
–
|
–
|
2
|
CO5
|
1
|
1
|
1
|
–
|
1
|
–
|